Total Payments
$2,446
2024 Payments
$871.89
Companies
27
Transactions
141
Medicare Patients
3,395
Medicare Billing
$365,536
Payment Breakdown by Category
Food & Beverage$2,409 (98.5%)
Other$20.00 (0.8%)
Education$16.90 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,409 | 138 | 98.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.8% |
| Education | $16.90 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $649.51 | 43 | $0 (2024) |
| PFIZER INC. | $454.81 | 28 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $338.17 | 24 | $0 (2024) |
| SK Life Science, Inc. | $249.16 | 2 | $0 (2024) |
| Amgen Inc. | $117.18 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $104.27 | 7 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $54.31 | 4 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $43.08 | 3 | $0 (2019) |
| QOL Medical, LLC | $40.44 | 3 | $0 (2018) |
| GENZYME CORPORATION | $37.84 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $871.89 | 41 | ABBVIE INC. ($208.25) |
| 2023 | $272.90 | 17 | PFIZER INC. ($134.77) |
| 2022 | $288.26 | 12 | SK Life Science, Inc. ($124.16) |
| 2021 | $14.97 | 1 | AbbVie Inc. ($14.97) |
| 2020 | $53.74 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($14.12) |
| 2019 | $334.70 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($141.70) |
| 2018 | $330.44 | 25 | AbbVie, Inc. ($115.42) |
| 2017 | $279.42 | 17 | AbbVie, Inc. ($175.76) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: VIROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/02/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/27/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Immunology | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Immunology | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/09/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Education | In-kind items and services | $8.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Education | In-kind items and services | $8.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/21/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Rare Disease | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 876 | 982 | $800,498 | $104,841 |
| 2022 | 13 | 808 | 890 | $698,443 | $87,511 |
| 2021 | 15 | 822 | 959 | $710,188 | $90,522 |
| 2020 | 15 | 889 | 1,037 | $676,927 | $82,662 |
Total Patients
3,395
Total Services
3,868
Medicare Billing
$365,536
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 237 | 306 | $106,794 | $31,379 | 29.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 97 | 97 | $184,058 | $18,887 | 10.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 175 | $41,125 | $12,025 | 29.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 110 | 113 | $180,235 | $10,694 | 5.9% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2023 | 30 | 30 | $70,500 | $7,140 | 10.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $22,880 | $6,407 | 28.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 29 | 29 | $49,126 | $4,902 | 10.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 61 | 61 | $110,715 | $4,819 | 4.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $14,784 | $3,193 | 21.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $11,826 | $2,996 | 25.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 35 | $5,005 | $1,387 | 27.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 15 | $3,450 | $1,012 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 244 | 314 | $73,790 | $21,707 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 139 | $48,511 | $13,584 | 28.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 72 | 72 | $136,620 | $12,934 | 9.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 101 | 102 | $162,690 | $8,643 | 5.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $20,240 | $5,957 | 29.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 54 | 54 | $98,010 | $5,283 | 5.4% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $54,050 | $5,025 | 9.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 33 | 33 | $55,902 | $4,525 | 8.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $11,968 | $2,943 | 24.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 14 | 14 | $23,716 | $2,676 | 11.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $6,570 | $1,726 | 26.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 31 | 32 | $4,576 | $1,493 | 32.6% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2022 | 12 | 12 | $1,800 | $1,017 | 56.5% |
About Dr. Shamina Dhillon, M.D
Dr. Shamina Dhillon, M.D is a Gastroenterology healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992779300.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shamina Dhillon, M.D has received a total of $2,446 in payments from pharmaceutical and medical device companies, with $871.89 received in 2024. These payments were reported across 141 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,409).
As a Medicare-enrolled provider, Dhillon has provided services to 3,395 Medicare beneficiaries, totaling 3,868 services with total Medicare billing of $365,536. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Oakhurst, NJ
- Active Since 02/14/2006
- Last Updated 03/31/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1992779300
Products in Payments
- XELJANZ (Drug) $386.12
- Entyvio (Biological) $273.55
- XCOPRI (Drug) $249.16
- KRYSTEXXA (Biological) $117.18
- SKYRIZI (Biological) $105.46
- RINVOQ (Biological) $100.91
- Mavyret (Drug) $97.33
- Humira (Biological) $92.84
- ENTYVIO (Biological) $92.50
- Creon (Drug) $91.55
- VELSIPITY (Drug) $68.69
- TREMFYA (Drug) $64.86
- DUPIXENT (Biological) $54.68
- DIFICID (Drug) $43.08
- Sucraid (Drug) $40.44
- STELARA (Biological) $39.41
- Viekira (Drug) $38.34
- CREON (Drug) $36.37
- XIFAXAN (Drug) $33.37
- MAVYRET (Drug) $32.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oakhurst
Laleh Merikhi, M.d, M.D
Gastroenterology — Payments: $13,511
Gastroenterology $13,511
Ben Terrany, Md, MD
Gastroenterology — Payments: $9,191
Gastroenterology $9,191
Junsuke Maki, Md, MD
Gastroenterology — Payments: $6,862
Gastroenterology $6,862
Dr. Mitchell Schwartz, M.d, M.D
Gastroenterology — Payments: $2,458
Gastroenterology $2,458
Dr. Penny Turtel, Md, MD
Gastroenterology — Payments: $2,429
Gastroenterology $2,429
Alexander Browne, M.d, M.D
Gastroenterology — Payments: $2,305
Gastroenterology $2,305